Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.086 | A novel fat-water imaging method through spatial and temporal domain approach and applications for MR cartilage and abdomen imaging | Dr Yuan Jing |
| 2017.621 | A novel imaging marker facilitates early identification of small vessel disease |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2022.661 | A novel integrative non-invasive embryo selection approach for in vitro fertilization based on artificial intelligence enhanced morphokinetic analysis and Raman spectra in spent culture media |
Prof. CHUNG Jacqueline Pui Wah 鍾佩樺 |
| 2018.178 | A novel NAFLD-LE model based on liver stiffness measurement and enhanced liver fibrosis (ELF) to predict clinical events in patients with non-alcoholic fatty liver disease |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2022.542 | A Novel Neuro-lmmune Axis MNT in Chronic Kidney Disease: From Molecular Mechanism to Clinical Implication | Dr. TANG Patrick Ming Kuen |
| 2015.292 | A novel non-invasive radial artery tonometric cardiovascular monitoring device for assessment of vascular aging, subclinical atherosclerosis and cardiovascular risk in the elderly. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2012.086 | A Novel Pharmacological Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease: A Randomized Double-blind Placebo-control Trial of Traditional Chinese Medicine Salviae miltiorhizae(Danshen) and Puerariae lobatae (Gegen) | Professor Yan Bryan Ping-Yen |
| 2015.018 | A novel preclinical treatment strategy for enhancing chemosensitivity of pediatric B-precursor acute lymphoblastic leukemia by disruption of leukemia-stroma interaction using CD9-neutralizing antibody in a mouse model | Dr. LEUNG Kam Tong |
| 2021.694 | A novel risk-stratified screening for non-alcoholic fatty liver disease and liver-related complications in patients with type 2 diabetes mellitus: A territory-wide cohort study |
Dr. YIP Cheuk Fung 葉卓風 |
| 2021.472 | A NOVEL ROBOTIC SURGICAL SYSTEM FOR MINIMALLY INVASIVE SURGERY: A PROSPECTIVE, SINGLE CENTER, MULTISPECIALTY STUDY | Prof. NG Simon Siu Man |
| 2016.348 | A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery: A Prospective, Single Center, Multispecialty Study |
Prof. NG Simon Siu Man 吳兆文 |
| 2019.112 | A NOVEL ROBOTIC SYSTEM FOR SINGLE PORT ENDOSCOPIC SURGERY: A PROSPECTIVE, SINGLE CENTER, MULTISPECIALTY STUDY | Prof. CHIU Philip Wai Yan |
| 2009.432 | A novel strategy for enriching fetal DNA in maternal plasma | CHIM Siu Chung Stephen |
| 2004.133 | A Novel Strategy to Prevent Radiotherapy-related Carotid Stenosis in Nasopharyngeal Carcinoma Patient: A Clinical Model of Accelerated Atherosclerosis | Prof. Chan Y.K. Thomas |
| 2023.479 | A novel synbiotic formula for anxiety and sensory hyperresponsiveness symptoms in children with autism spectrum disorder: A multicenter, double-blinded, randomized controlled trial | Dr. WONG Oscar Wing Ho |
| 2018.068 | A nurse-coordinated integrated care model to support decision-making and self-care in patients with atrial fibrillation: A randomized controlled trial | Prof. YAN Bryan Ping Yen |
| 2014.003 | A Nurse-led End-of-life (EOL) Program for frail elders with end stage chronic diseases | Prof. YU Doris Sau Fung |
| 2024.264 | A nurse-led lifestyle modification intervention for enhancing self-efficacy, illness perception, self-care management and steatosis grade among patients with metabolic dysfunction-associated steatotic liver disease: A pilot randomised controlled trial | Ms. MA Angel Cho Kan |
| 2023.300 | A nurse-led lifestyle modification intervention for enhancing self-efficacy, illness perception, self-care management and steatosis grade among patients with non-alcoholic fatty liver disease: A randomised controlled trial | Ms. MA Angel Cho Kan |
| 2024.122 | A Nursing Student-Supported Mobile Health Intervention for South Asians in Hong Kong: A Feasibility Study | Dr. CHAN Dorothy N.S. |
| 2021.664 | A one-time point, cross-sectional and observatory survey to identify the nutritional status of Inflammatory Bowel Disease (IBD) patients including Ulcerative Colitis (UC) and Crohn's Disease (CD) in the IBD clinic of Prince of Wales Hospital (PWH). |
Ms. LAM Ka Sheung 林家嫦 |
| 2005.149 | A One-Year, Open-Label, Single Arm, Multi-Center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20mg/kg/day) in Patients Diagnosed with Transfusion-dependent Iron Overload | Dr. Li Chi Kong |
| 2003.273 | A One-Year, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Effect and Safety of A Herbal Capsule | Prof. Leung Ping Chung |
| 2020.411 | A one–year prospective study for intrapleural pressure for thoracentesis | Dr. LUN Chung Tat |
| 2003.277 | A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, with Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events in Patients with Atrial Fibrillation | Dr. Fung Wing Hong |
| 2016.360 | A parallel-group comparison of active noise cancellation headphones and ear plugs in subjective assessment and blood pressure profile of subjects exposure to loud noise |
Prof. TONG Michael Chi Fai 唐志輝 |
| 2005.254 | A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar Therapy in Patients with Type 2 Diabetes Mellitus (GALLEX 4) | Prof. Chan C.N. Juliana |
| 2010.367 | A Paramedian Transverse Oblique Scan through the Lumbar Inter-transverse Space is the Optimal Window for Imaging the Anatomy Relevant for Lumbar Plexus Block | KARMAKAR Manoj Kumar |
| 2024.607 | A Patient Registry for Early Detection and Management of Alzheimer’s Disease in Hong Kong | Prof. MOK Vincent Chung Tong |
| 2025.062 | A personalized closed-loop bio neurofeedback training protocol to improve emotion sensitivity in adolescents with Autism Spectrum Disorder (ASD) |
Dr. WANG Yang Yang WANG |
| 2020.375 | A Pharmacoeconomic Assessment of Pegaspargase versus Native Asparaginase in Children with Leukemia in Hong Kong. |
Prof. LEE Wing Yan Vivian 李詠恩 |
| 2017.567 | A pharmacokinetic study of simvastatin with Cistanches Herba – a final step to support their combined use in patients with statin-induced muscle toxicity. |
Prof. LAU Clara Bik San 劉碧珊 |
| 2002.074 | A Pharmacokinetic-Genomic Approach for Predicting Herb-Drug Interactions:An Initial Evaluation Using Ginkgo Biloba | Prof. Chow Sing Sum Moses |
| 2009.354 | A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection | Dr Hui Aric Josun |
| 2009.404 | A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection | Prof. SUNG Joseph JY |
| 2009.621 | A pharyngea foreign body presenting as a painful neck mass | LEUNG Moon Wah Natalie |
| 2002.417A | A Phase Iib Extension Study of LdT (Telbivudine), Lamivudine, or LdT plus Lamivudine in Patients with Chronic Hepatitis B who Have Completed Study NV-02B-003 (Protocol Number : NV-02B-010) | Dr. Leung Wai Yee Nancy |
| 2008.068 | A Phase 1 / 2 Study of CMC-544 Administered in Combination with Rituximab in Subjects with Follicular or Diffuse Large B-Cell Non-Hodgkin’s Lymphoma | Prof. WONG Raymond Siu Ming |
| 2024.368 | A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors (AMBER) | Prof. CHAN Stephen Lam |
| 2012.044 | A Phase 1 Dose Escalation and Pharmacokinetic Study of Alisertib (MLN8237), an Aurora A Kinase Inhibitor, in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas | Dr. Ma Brigette Buig Yue |
| 2012.292 | A Phase 1 Pharmacokinetic and Tolerability Study of Oral MLN9708 Plus Lenalidomide and Dexamethasone in Adult Asian Patients With Relapsed and/or Refractory Multiple Myeloma | Dr. WONG Raymond Siu Ming |
| 2021.456 | A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Tarlatamab in Subjects With Small Cell Lung Cancer (DeLLphi-300) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.493 | A Phase 1 Study of BOS172738 in Patients with Advanced Solid Tumors with RET Gene Alterations including Non-Small Cell Lung Cancer (NSCLC) and Medullary Thyroid Cancer (MTC) | Dr. LOONG Herbert Ho Fung |
| 2020.565 | A Phase 1 Study of LY3410738 Administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2016.393 | A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BLU-554 in Patients with Hepatocellular Carcinoma |
Dr. CHAN Stephen Lam 陳林 |
| 2019.151 | A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GS-4224 in Healthy Volunteers and Subjects with the Chronic Hepatitis B (CHB) Virus |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2023.200 | A Phase 1, Double-Blind, Randomized, Placebo-Controlled, First-in-Human Study of Orally Administered ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single-Ascending Doses (Part 1) and Multiple-Ascending Doses in Healthy Volunteers (Part 2), and Multiple Doses in Subjects with Chronic Hepatitis B (Part 3) |
Prof. WONG Grace Lai Hung Grace LH Wong |
| 2019.386 | A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART® Protein binding PD-1 and LAG-3 in Patients with Unresectable or Metastatic Neoplasms | Dr. LOONG Herbert Ho Fung |
| 2019.554 | A Phase 1, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects of Chinese Descent With Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 105) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2020.366 | A Phase 1, Open-Label, Multicenter Study to Assess the Safety and Tolerability of mRNA-5671/V941 as a Monotherapy and in Combination with Pembrolizumab in Participants with KRAS Mutant Advanced or Metastatic Non-Small Cell Lung Cancer, Colorectal Cancer or Pancreatic Adenocarcinoma |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
Page 15 of 262.